Works matching IS 01145916 AND DT 2020 AND VI 43 AND IP 10

Results: 10

Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 981, doi. 10.1007/s40264-020-00963-y

By:

Barnes, Joanne;
Sheridan, Jane L.;
Dong, Christine Yang;
Härmark, Linda;
Vohra, Sunita;
Harrison-Woolrych, Mira

Publication type:

Article

Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 957, doi. 10.1007/s40264-020-00962-z

By:

Edwards, Adam B.;
Mastaglia, Frank L.;
Knuckey, Neville W.;
Meloni, Bruno P.

Publication type:

Article

Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 1023, doi. 10.1007/s40264-020-00961-0

By:

Li, Xue;
Pathadka, Swathi;
Man, Kenneth K. C.;
Ng, Vanessa W. S.;
Siu, Chung Wah;
Wong, Ian C. K.;
Chan, Esther W.;
Lau, Wallis C. Y.

Publication type:

Article

The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 1011, doi. 10.1007/s40264-020-00959-8

By:

Webster, Rebecca K.;
Rubin, G. James

Publication type:

Article

Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 953, doi. 10.1007/s40264-020-00991-8

By:

Bendstrup, Elisabeth;
Kalluri, Meena

Publication type:

Article

Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 971, doi. 10.1007/s40264-020-00978-5

By:

Kolonics-Farkas, Abigél M.;
Šterclová, Martina;
Mogulkoc, Nesrin;
Kus, Jan;
Hájková, Marta;
Müller, Veronika;
Jovanovic, Dragana;
Tekavec-Trkanjec, Jasna;
Littnerová, Simona;
Hejduk, Karel;
Vašáková, Martina

Publication type:

Article

Use of Pregabalin and Worsening Heart Failure: A Nationwide Cohort Study.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 1035, doi. 10.1007/s40264-020-00969-6

By:

Lund, Marie;
Poulsen, Gry;
Pasternak, Björn;
Worm Andersson, Niklas;
Melbye, Mads;
Svanström, Henrik

Publication type:

Article

Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 1057, doi. 10.1007/s40264-020-00967-8

By:

Wang, Shirley V.;
Stefanini, Kristina;
Lewis, Edwin;
Newcomer, Sophia R.;
Fireman, Bruce;
Daley, Matthew F.;
Glanz, Jason M.;
Duffy, Jonathan;
Weintraub, Eric;
Kulldorff, Martin

Publication type:

Article

Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 1045, doi. 10.1007/s40264-020-00964-x

By:

Lewis, James H.;
Cottu, Paul H.;
Lehr, Martin;
Dick, Evan;
Shearer, Todd;
Rencher, William;
Bexon, Alice S.;
Campone, Mario;
Varga, Andrea;
Italiano, Antoine

Publication type:

Article

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase.

Published in:

Drug Safety, 2020, v. 43, n. 10, p. 999, doi. 10.1007/s40264-020-00957-w

By:

Sandberg, Lovisa;
Taavola, Henric;
Aoki, Yasunori;
Chandler, Rebecca;
Norén, G. Niklas

Publication type:

Article